Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician.

Mayo Clinic Proceedings
Andrew S TsengChristopher V DeSimone

Abstract

The management of atrial fibrillation (AF) in the outpatient setting has become more complex with the utilization of antiarrhythmic drugs (AADs) and increasing complexity of comorbid conditions. The primary care clinician is critically involved in the pharmacologic management of AF, whether it be direct prescription of AADs or managing potential drug-drug interactions with other medications. In this review, we provide instructive, high-yield clinical scenarios and quick clinical references to increase familiarity and comfort with the use of AADs.

References

Aug 22, 1991·The New England Journal of Medicine
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Nov 22, 2000·Circulation·J P Mounsey, J P DiMarco
Feb 24, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·P Dorian, D Newman
Jul 18, 2002·The American Journal of the Medical Sciences·Roya M SameriTimothy H Self
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Nov 9, 2004·Lancet·Bo CarlbergLars Hjalmar Lindholm
Mar 24, 2007·BMJ : British Medical Journal·A John Camm, Irina Savelieva
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Patricia Vassallo, Richard G Trohman
Mar 17, 2010·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN RACE II Investigators
May 4, 2013·Alimentary Pharmacology & Therapeutics·J H Lewis, J G Stine
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Apr 8, 2014·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Lindsey W Crist, Dave L Dixon
May 6, 2015·European Heart Journal·Mate VamosStefan H Hohnloser
Aug 25, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew G McDonaldAllan E Rettie
Mar 10, 2017·Cardiovascular Therapeutics·Stephen RankinAnna Maria Choy
Jan 7, 2018·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jason G AndradeMarc W Deyell
Mar 10, 2018·Journal of the American College of Cardiology·Renato D LopesUNKNOWN ARISTOTLE Committees and Investigators
May 12, 2018·Journal of the American College of Cardiology·Arman QamarRobert P Giugliano
Jul 24, 2018·The American Journal of Emergency Medicine·Ivan ComelliGianfranco Cervellin
Sep 1, 2020·The New England Journal of Medicine·Paulus KirchhofUNKNOWN EAST-AFNET 4 Trial Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

The Canadian Journal of Cardiology
Paul Angaran, Paul Dorian
Journal of Cardiovascular Pharmacology and Therapeutics
Jonathan W Waks, Peter Zimetbaum
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Jordi HeijmanA John Camm
Recent Patents on Cardiovascular Drug Discovery
Francesca SalghettiAntonio Curnis
© 2021 Meta ULC. All rights reserved